Current advances in the diagnosis and treatment of pancreatic endocrine tumors

Current Opinion in Oncology

Volumn 17, Issue 1, 2005, Pages 24-27

  Viola, Kate V ^a   Sosa, Julie Ann ^b  

^a SAMFORD UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endocrine pancreas; Gastrinoma; Insulinoma; MEN 1

Indexed keywords

CHROMOGRANIN A; GEFITINIB; IMATINIB; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ANGIOGRAPHY; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE TUMOR; HUMAN; INSULIN RELEASE; INSULIN SYNTHESIS; INSULINOMA; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PANCREATIC ENDOCRINE TUMOR; PRIORITY JOURNAL; REVIEW; TUBEROUS SCLEROSIS; ULTRASOUND; VON HIPPEL LINDAU DISEASE;

CHROMOGRANIN A; CHROMOGRANINS; GASTRINOMA; HUMANS; INCIDENCE; INSULINOMA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 13144262806     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000147902.50442.28     Document Type: Review

References (14)

1. Chun J, Doherty GL: Pancreatic endocrine tumors. Current Opinion in Oncology 2001, 13:52-56.
2. Minn A, Kayton M, Lorang D, et al.: Insulinomas and expression of an insulin splice variant. Lancet 2004, 363:363-367. A comprehensive review of the genetics of insulinoma.
3. Kikuchi M, Ohkura N, Yamaguchi K, et al.: Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1. Cancer Letters 2004, 208:81-88.
4. Gibril F, Schumann M, Pace A, et al.: Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 2004, 83:43-83. A cohort study identifying several new clinical findings in MEN-1-ZES.
5. Lairmore T, Piersall L, DeBenedetti M, et al.: Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Annals of Surgery 2004, 5:637-647. Indication for surgical intervention in asymptomatic, Men-1 positive patients.
6. Finlayson E, Clark O: Surgical treatment of insulinomas. Surgical Clinics of North America 2004, 3:1-8.
7. Nehar D, Lombard B, Olivieri C, et al.: Interest of chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol (Oxf) 2004, 60:644-652. Support for how chromogranin A can be used in the diagnosis and staging of endocrine tumors.
8. Van Nieuwenhove Y, Vandaele S, Op de Beeck B, et al.: Neuroendocrine tumors of the pancreas benefits of new technologies. Surgical Endoscopy 2003, 17:1658-1662.
9. Ahlstrom H, Eriksson B, Bergstrom M, et al.: Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995, 195:333-337.
10. Becherer A, Szabo M, Karanikas G, et al.: Imaging of advanced neuroendocrine tumors with 18 F-FDOPA PET. J Nucl Med 2003, 45:1161-1167.
11. Pfannenberg A, Eschmann S, Horger M, et al.: Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med 2003, 30:835-843. A radiologic study supporting the use of combined diagnostic modalities to optimize localization of endocrine tumors.
12. Gouya H, Vignaux O, Augui J, et al.: CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. Am J Roentgenol 2003, 181:987-991. Another radiologic study that provides an imaging algorithm for insulinomas.
13. Woltering E: Development of targeted somatostatin-based antiangiogenic therapy: a review and future perspectives. Cancer Biother Radiopharm 2003, 18:601-609. A summary of various models using octreotide to inhibit angiogenesis.
14. Fjallskog M, Lejonklou M, Oberg K, et al.: Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin Cancer Res 2003, 9:1469-1473. Immunohistochemical examination shows tyrosine kinase receptors are common on malignant endocrine pancreatic tumors.